Healthcare
20/20 BioLabs
Coming October 5, 2026
OneTest measures established protein tumor markers and uses machine learning to identify patterns associated with multiple cancers.
OneTest measures established protein tumor markers and uses machine learning to identify patterns associated with multiple cancers.
Brook is giving health systems the technology, clinical teams, and infrastructure to support patients beyond the traditional office visit
PortIO is developing the first implantable intraosseous port for long-term vascular access.
Axena Health is a commercial-stage women’s health company focused on transforming the treatment of urinary incontinence.
Meet the CEO of Bayou Surgical in Boston to hear how the company is redefining visualization for both laparoscopic and robotic procedures
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
Beren Therapeutics is developing a new class of medicines targeting numerous neurodegenerative diseases, including Alzheimer’s.
A new therapeutic modality designed to directly target and destroy disease gene sequences rather than simply treat the symptoms of a disease
How leading scientists determine which discoveries have the potential to become meaningful new therapies.
HDT Bio is developing a new immune-maintenance therapy for HER2-positive breast cancer patients designed for the years after successful treatment.
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Aneira has developed a proprietary topical formulation designed to stimulate hair growth for both men and women